Breaking News

NovAliX Acquires Sanofi Site in Strasbourg

Creates Guy Ourisson Research Campus boosting research capacity with plans to set up therapeutic innovation campus and center for cryo-electron microscopy.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

NovAliX, a Contract Research Organization (CRO) specializing in drug research and development, has acquired Sanofi’s 3.7 acre site, including a 86,000 sq.-ft. building designed to the highest standards for pharmaceutical research.   This represents the first stage in its development project that will allow it to offer clients a more complete, high-quality portfolio with enhanced biological and pharmacological services.   The site will be known as the Guy Ourisson Research Campus and will be ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters